Testing anxiolytic drugs in the C57BL/6J mouse strain

Journal of Pharmacological and Toxicological Methods

Volumn 69, Issue 2, 2014, Pages 205-207

  Kalueff, Allan V ^a   Nguyen, Michael ^b  

^a ZENEREI Institute   (United States)

^b University of Virginia   (United States)

Author keywords

Anxiety; Behavioral testing; Brain disorders; C57BL 6J mice

Indexed keywords

CHLORDIAZEPOXIDE; ANXIOLYTIC AGENT; METHYLPHENIDATE; PICROTOXIN;

ACCURACY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SCREENING; LETTER; LOW DRUG DOSE; METHODOLOGY; MOUSE; NONHUMAN; PSYCHOLOGIC TEST; RODENT; ANIMAL; ANXIETY; DARKNESS; DRUG EFFECTS; DRUG THERAPY; LIGHT; MALE; MAZE TEST; PSYCHOLOGY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DARKNESS; LIGHT; MALE; MAZE LEARNING; METHYLPHENIDATE; PICROTOXIN;

EID: 84896869970     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2014.01.004     Document Type: Letter

References (50)

1. Agetsuma M., Aizawa H., Aoki T., Nakayama R., Takahoko M., Goto M., et al. The habenula is crucial for experience-dependent modification of fear responses in zebrafish. Nature Neuroscience 2010, 13:1354-1356.
2. Bailey K.R., Rustay N.R., Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: Practical concerns and potential pitfalls. ILAR Journal 2006, 47:124-131.
3. Belzung C., Dubreuil D. Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice. Behavioural Pharmacology 1998, 9:691-698.
4. Belzung C., Le Guisquet A.M., Crestani F. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice. Psychopharmacology 2000, 148:24-32.
5. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
6. Bussey T.J., Holmes A., Lyon L., Mar A.C., McAllister K.A., Nithianantharajah J., et al. New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats. Neuropharmacology 2012, 62:1191-1203.
7. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research 1999, 835:18-26.
8. Crawley J.N. Behavioral phenotyping of rodents. Comparative Medicine 2003, 53:140-146.
9. Crawley J.N. Behavioral phenotyping strategies for mutant mice. Neuron 2008, 57:809-818.
10. Crawley J.N., Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones and Behavior 1997, 31:197-211.
11. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nature Reviews. Drug Discovery 2005, 4:775-790.
12. Cryan J.F., Sweeney F.F. The age of anxiety: Role of animal models of anxiolytic action in drug discovery. British Journal of Pharmacology 2011, 164:1129-1161.
13. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task. Behavioural Brain Research 2008, 188:136-153.
14. Fraser L.M., Brown R.E., Hussin A., Fontana M., Whittaker A., O'Leary T.P., et al. Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests. Psychopharmacology 2010, 211:99-112.
15. Heredia L., Torrente M., Colomina M.T., Domingo J.L. Assessing anxiety in C57BL/6J mice: A pharmacological characterization of the open-field and light/dark tests. Journal of Pharmacological and Toxicological Methods 2013, 69:108-114.
16. Heredia L., Torrente M., Colomina M.T., Domingo J.L. Assessing anxiety in C57BL/6J mice: A pharmacological characterization of the zero maze test. Journal of Pharmacological and Toxicological Methods 2013, 68:275-283.
17. Hitzemann B., Hitzemann R. Chlordiazepoxide-induced expression of c-Fos in the central extended amygdala and other brain regions of the C57BL/6J and DBA/2J inbred mouse strains: Relationships to mechanisms of ethanol action. Alcoholism, Clinical and Experimental Research 1999, 23:1158-1172.
18. Hussin A.T., Fraser L.M., Ramos A., Brown R.E. The effect of chlordiazepoxide on measures of activity and anxiety in Swiss-Webster mice in the triple test. Neuropharmacology 2012, 63:883-889.
19. Ihne J.L., Fitzgerald P.J., Hefner K.R., Holmes A. Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice. Neuropharmacology 2012, 62:464-473.
20. Kalueff A.V., LaPorte J.L., Murphy D.L., Sufka K. Hybridizing behavioral models: a possible solution to some problems in neurophenotyping research?. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:1172-1178.
21. Kalueff A.V., Schmidt M.V. Novel experimental models and paradigms for neuropsychiatric disorders: Editorial. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, 35:1355-1356.
22. Kalueff A.V., Tuohimaa P. Contrasting grooming phenotypes in C57Bl/6 and 129S1/SvImJ mice. Brain Research 2004, 1028:75-82.
23. Kalueff A.V., Tuohimaa P. Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs. European Journal of Pharmacology 2005, 508:147-153.
24. Kalueff A.V., Tuohimaa P. The Suok ("ropewalking") murine test of anxiety. Brain Research. Brain Research Protocols 2005, 14:87-99.
25. Kalueff A.V., Wheaton M., Murphy D.L. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behavioural Brain Research 2007, 179:1-18.
26. Kas M.J., de Mooij-van Malsen A.J., Olivier B., Spruijt B.M., van Ree J.M. Differential genetic regulation of motor activity and anxiety-related behaviors in mice using an automated home cage task. Behavioral Neuroscience 2008, 122:769-776.
27. Koenig H.G., George L.K., Schneider R. Mental health care for older adults in the year 2020: A dangerous and avoided topic. Gerontologist 1994, 34:674-679.
28. Kyzar E., Gaikwad S., Roth A., Green J., Pham M., Stewart A., et al. Towards high-throughput phenotyping of complex patterned behaviors in rodents: Focus on mouse self-grooming and its sequencing. Behavioural Brain Research 2011, 225:426-431.
29. Lapin I.P. A decreased frequency of peeking out from the dark compartment-The only constant index of the effect of anxiogens on the behavior of mice in a "light-darkness" chamber. Zhurnal Vyssheǐ Nervnoǐ Deiatelnosti Imeni I P Pavlova 1999, 49:521-526.
30. Lapin I.P., Nazarenko S.E. Differences between dose-effect curves for ethanol on locomotion and rearings in mice of various strains. Biulleten' Eksperimental'noǐ Biologii i Meditsiny 1979, 88:31-32.
31. Maaswinkel H., Zhu L., Weng W. Assessing social engagement in heterogeneous groups of zebrafish: A new paradigm for autism-like behavioral responses. PLoS One 2013, 8:e75955.
32. Mar A.C., Horner A.E., Nilsson S.R., Alsio J., Kent B.A., Kim C.H., et al. The touchscreen operant platform for assessing executive function in rats and mice. Nature Protocols 2013, 8:1985-2005.
33. Mathiasen L.S., Mirza N.R., Rodgers R.J. Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice. Pharmacology, Biochemistry, and Behavior 2008, 90:19-36.
34. Mathis C., Paul S., Crawley J. Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behavior Genetics 1994, 24:171-180.
35. Michalikova S., van Rensburg R., Chazot P.L., Ennaceur A. Anxiety responses in Balb/c, c57 and CD-1 mice exposed to a novel open space test. Behavioural Brain Research 2010, 207:402-417.
36. Murphy J.M. Trends in depression and anxiety: men and women. Acta Psychiatrica Scandinavica 1986, 73:113-127.
37. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nature Neuroscience 2010, 13:1161-1169.
38. Norwood K., McGovern S.F., Kennedy P.J., Shaw D., Leslie J.C. Effects of chlordiazepoxide on runway behaviours of C57Bl/6 mice under continuous or partial reinforcement. Behavioural Pharmacology 2011, 22:167-172.
39. Olsson I.A., Sherwin C.M. Behaviour of laboratory mice in different housing conditions when allowed to self-administer an anxiolytic. Laboratory Animals 2006, 40:392-399.
40. Oomen C.A., Hvoslef-Eide M., Heath C.J., Mar A.C., Horner A.E., Bussey T.J., et al. The touchscreen operant platform for testing working memory and pattern separation in rats and mice. Nature Protocols 2013, 8:2006-2021.
41. Paris J.J., Singh H.D., Ganno M.L., Jackson P., McLaughlin J.P. Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology 2013, 10.1007/s00213-013-3385-1.
42. Revest J.M., Dupret D., Koehl M., Funk-Reiter C., Grosjean N., Piazza P.V., et al. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Molecular Psychiatry 2009, 14:959-967.
43. Rodgers R.J., Davies B., Shore R. Absence of anxiolytic response to Chlordiazepoxide in two common background strains exposed to the elevated plus-maze: Importance and implications of behavioural baseline. Genes, Brain, and Behavior 2002, 1:242-251.
44. Sansone M. Influence of benzodiazepine tranquilizers on amphetamine-induced locomotor stimulation in mice. Psychopharmacology 1980, 71:63-65.
45. Smith K.S., Engin E., Meloni E.G., Rudolph U. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice. Neuropharmacology 2012, 63:250-258.
46. Smith K.S., Meloni E.G., Myers K.M., Van't Veer A., Carlezon W.A., Rudolph U. Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice. Psychopharmacology 2011, 213:697-706.
47. Stewart A.M., Kalueff A.V. Anxiolytic drug discovery: What are the novel approaches and how can we improve them?. Expert Opinion on Drug Discovery 2014, 9:15-26.
48. Twenge J.M. The age of anxiety? Birth cohort change in anxiety and neuroticism, 1952-1993. Journal of Personality and Social Psychology 2000, 79:1007-1021.
49. Verleye M., Dumas S., Heulard I., Krafft N., Gillardin J.M. Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: any relation to overexpression of central GABAA receptor beta2 subunits?. European Neuropsychopharmacology 2011, 21:457-470.
50. Young J.W., Minassian A., Paulus M.P., Geyer M.A., Perry W. A reverse-translational approach to bipolar disorder: Rodent and human studies in the behavioral pattern monitor. Neuroscience and Biobehavioral Reviews 2007, 31:882-896.